Cochlear
Australia - Macquarie ParkMedical Devices
Focus: Cochlear is a global leader in implantable hearing solutions, headquartered in Australia and specializing in cochlear implants, bone-conduction implants, and related hearing restoration devices. The company operates as a established medical device manufacturer with a broad portfolio of FDA-cleared and CE-marked systems.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Cochlear
AI assessmentNot HiringNo open roles listed right now. Follow Cochlear to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Cochlear™ Nucleus® System
Stable
Peak
Flagship cochlear implant platform with continuous processor and electrode iterations (Nucleus 8, Nucleus Nexa, CP950, CP1170).
Help build intelligence for Cochlear
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.